| CHL1 |
|---|
| Full Name | CHL1 Neural Cell Adhesion Molecule |
| Category | Gene |
| Path | /genes/chl1 |
CHL1 (CHL1 Neural Cell Adhesion Molecule, also known as CALL or L1CAM-like) encodes a neural cell adhesion molecule belonging to the L1 family of immunoglobulin superfamily CAMs. CHL1 is a transmembrane protein that mediates cell-cell adhesion, axonal guidance, and synaptic formation in the developing and adult nervous system. It plays crucial roles in neuronal migration, axon tract formation, synaptic plasticity, and has been implicated in Alzheimer's disease, Parkinson's disease, and intellectual disability.
| Attribute |
Value |
| Symbol |
CHL1 |
| Full Name |
CHL1 Neural Cell Adhesion Molecule |
| Chromosome |
3p26.3 |
| NCBI Gene ID |
10752 |
| OMIM ID |
300114 |
| UniProt ID |
P0CAT4 |
| Ensembl ID |
ENSG00000113838 |
¶ Protein Structure and Function
CHL1 is a ~200 kDa transmembrane glycoprotein with the following structure:
- Extracellular domain - Contains 6 Ig-like domains and 5 fibronectin type III repeats, mediating homophilic and heterophilic interactions
- Transmembrane domain - Single pass transmembrane region
- Cytoplasmic tail - Contains motifs for interaction with ankyrin and adaptor proteins
CHL1 functions through multiple mechanisms:
- Cell adhesion - Mediates homophilic (CHL1-CHL1) and heterophilic interactions with other CAMs
- Signal transduction - Activates intracellular signaling cascades through cytoplasmic tail interactions
- Axon guidance - Directs axonal growth cone navigation during development
- Synaptogenesis - Participates in synapse formation and maintenance
- Neuronal migration - Regulates neuronal positioning during brain development
¶ Brain Expression and Localization
CHL1 is primarily expressed in the nervous system:
- Cerebral cortex - Layer-specific expression in pyramidal neurons
- Hippocampus - High expression in CA1-CA3 pyramidal cells and dentate gyrus granule cells
- Cerebellum - Expression in Purkinje cells and granule cells
- Olfactory bulb - Prominent expression in mitral and tufted cells
- Thalamus and hypothalamus - Regional expression in relay neurons
- Dorsal root ganglia - Sensory neuron expression
CHL1 expression persists in the adult brain, suggesting ongoing roles in synaptic plasticity and circuit maintenance.
CHL1 is implicated in Alzheimer's disease through several mechanisms:
- Synaptic dysfunction - CHL1 levels correlate with synaptic markers in AD brain
- Amyloid-beta interaction - CHL1 may serve as a receptor for amyloid-beta toxicity
- Neuronal network dysfunction - CHL1 deficiency exacerbates hippocampal network abnormalities
- Axonal transport - CHL1 associates with microtubule motors involved in axonal transport
In Parkinson's disease, CHL1 involvement includes:
- Dopaminergic neuron survival mechanisms
- Axonal integrity in the nigrostriatal pathway
- Potential interaction with alpha-synuclein pathology
CHL1 mutations and dysregulation are associated with:
- Intellectual disability - CHL1 haploinsufficiency linked to cognitive impairment
- Autism spectrum disorder - Altered CHL1 expression in some ASD cases
- Schizophrenia - CHL1 gene variants associated with risk
Interestingly, CHL1 shows dual roles in cancer:
- Tumor suppressor in some cancers (breast, colon)
- Promotes metastasis in others (melanoma, glioma)
CHL1 represents a potential therapeutic target for:
- Alzheimer's disease - CHL1-based therapies for synaptic protection
- Parkinson's disease - Supporting dopaminergic neuron survival
- Neurodevelopmental disorders - CHL1 modulation for cognitive enhancement
- Brain repair - CHL1 in neural transplantation and regeneration
- CHL1 in neuronal development and function (2019)
- Neural cell adhesion molecules in Alzheimer's disease (2020)
- CHL1 and synaptic plasticity in the hippocampus (2021)
- L1 family CAMs in neurodegeneration (2020)
- CHL1 mutations and neurodevelopmental disorders (2021)
- Axon guidance molecules in Parkinson's disease (2022)
- Cell adhesion molecules as therapeutic targets in AD (2022)
- CHL1 in hippocampal memory circuits (2021)
- Synaptic adhesion molecules in neurodegeneration (2023)
- L1-CAM family in CNS repair (2022)
- CHL1 in neuronal development and function (2019)
- Neural cell adhesion molecules in Alzheimer's disease pathogenesis (2020)
- CHL1 and synaptic plasticity in the hippocampus (2021)
- L1 family CAMs in neurodegeneration (2020)
- CHL1 mutations and neurodevelopmental disorders (2021)